Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ4 years ago
Covid-19 vaccine trial from AstraZeneca and the University of Oxford can resume in U.S., according to a person familiar with the matter on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ4 years ago
Biden administration officials told states that the U.S. will reallocate Covid-19 vaccine doses that go unordered to states that are in need of additional shots, a person familiar with the matter said on.wsj.com
@WSJ4 years ago
The FDA is investigating what caused a batch of the active ingredient for J&J’s Covid-19 vaccine to be scrapped, a person familiar with the matter said. on.wsj.com
